These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36402606)

  • 1. Use of neoadjuvant pexidartinib with limb salvage surgery for diffuse tenosynovial giant cell tumor: A case report.
    Geiger EJ; Jensen AR; Singh AS; Nelson SD; Bernthal NM
    J Orthop Sci; 2024 Jan; 29(1):458-462. PubMed ID: 36402606
    [No Abstract]   [Full Text] [Related]  

  • 2. ENLIVEN study: Pexidartinib for tenosynovial giant cell tumor (TGCT).
    Tap W
    Future Oncol; 2020 Sep; 16(25):1875-1878. PubMed ID: 32755241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USA.
    Dharmani C; Fofah O; Wang E; Salas M; Wooddell M; Tu N; Tse J; Near A; Tinoco G
    Future Oncol; 2024; 20(16):1079-1097. PubMed ID: 38380590
    [No Abstract]   [Full Text] [Related]  

  • 4. Tenosynovial giant cell tumor-diffuse type, treated with a novel colony-stimulating factor inhibitor, pexidartinib: initial experience with MRI findings in three patients.
    Helming A; Hansford B; Beckett B
    Skeletal Radiol; 2022 May; 51(5):1085-1091. PubMed ID: 34586485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects of Treating Tenosynovial Giant Cell Tumor through Pexidartinib: A Review.
    Alsayadi YMMA; Chawla PA
    Anticancer Agents Med Chem; 2021; 21(12):1510-1519. PubMed ID: 33143617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development.
    Benner B; Good L; Quiroga D; Schultz TE; Kassem M; Carson WE; Cherian MA; Sardesai S; Wesolowski R
    Drug Des Devel Ther; 2020; 14():1693-1704. PubMed ID: 32440095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal pigmented villonodular synovitis and tenosynovial giant cell tumor: A report of two cases and a comprehensive systematic review.
    Zeoli T; Mathkour M; Scullen T; Carr C; Abou-Al-Shaar H; Wang L; Divagaran A; Dindial R; Tubbs RS; Bui CJ; Maulucci CM
    Clin Neurol Neurosurg; 2021 Mar; 202():106489. PubMed ID: 33596487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective real-world study of the diffuse-type tenosynovial giant cell tumor patient journey: A 2-year observational analysis.
    Bernthal NM; Healey JH; Palmerini E; Bauer S; Schreuder H; Leithner A; Martin-Broto J; Gouin F; Lopez-Bastida J; Gelderblom H; Staals EL; Burke ZD; Geiger EJ; Spierenburg G; Laeis P; Beyerlein E; Ye X; van de Sande M
    J Surg Oncol; 2022 Dec; 126(8):1520-1532. PubMed ID: 36006054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifocal tenosynovial giant cell tumors in a child with Noonan syndrome.
    Meyers AB; Awomolo AO; Szabo S
    Pediatr Radiol; 2017 Mar; 47(3):361-365. PubMed ID: 27878339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis).
    Gouin F; Noailles T
    Orthop Traumatol Surg Res; 2017 Feb; 103(1S):S91-S97. PubMed ID: 28057477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distraction arthroplasty combined with autologous bone grafting for diffuse-type tenosynovial giant cell tumour with articular cartilage defect and subchondral bone cysts: A case report.
    Ikuta Y; Nakasa T; Sumii J; Nekomoto A; Kawabata S; Adachi N
    Mod Rheumatol Case Rep; 2023 Jun; 7(2):483-487. PubMed ID: 36484489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel CSF1R-positive tenosynovial giant cell tumor cell lines and their pexidartinib (PLX3397) and sotuletinib (BLZ945)-induced apoptosis.
    Thongchot S; Duangkaew S; Yotchai W; Maungsomboon S; Phimolsarnti R; Asavamongkolkul A; Thuwajit P; Thuwajit C; Chandhanayingyong C
    Hum Cell; 2023 Jan; 36(1):456-467. PubMed ID: 36456782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse-Type Tenosynovial Giant Cell Tumor An Update of Current Management Strategies.
    Naja A; Abboud A; Masrouha K; Ghert M; Saghieh S
    Bull Hosp Jt Dis (2013); 2024 Sep; 82(3):178-185. PubMed ID: 39150871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment updates on tenosynovial giant cell tumor.
    Palmerini E; Staals EL
    Curr Opin Oncol; 2022 Jul; 34(4):322-327. PubMed ID: 35837703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study.
    Mastboom MJL; Palmerini E; Verspoor FGM; Rueten-Budde AJ; Stacchiotti S; Staals EL; Schaap GR; Jutte PC; Aston W; Gelderblom H; Leithner A; Dammerer D; Takeuchi A; Thio Q; Niu X; Wunder JS; ; van de Sande MAJ
    Lancet Oncol; 2019 Jun; 20(6):877-886. PubMed ID: 31029509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct extra-articular invasion patterns of diffuse pigmented villonodular synovitis/tenosynovial giant cell tumor in the knee joints.
    Kim DE; Kim JM; Lee BS; Kim NK; Lee SH; Bin SI
    Knee Surg Sports Traumatol Arthrosc; 2018 Nov; 26(11):3508-3514. PubMed ID: 29637236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenosynovial Giant Cell Tumor in an Infant.
    Shahriari S; Ederle A; Botros J; Elwood H; Shetty A
    J Craniofac Surg; 2020 Sep; 31(6):1760-1762. PubMed ID: 32472881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rare case of localised pigmented villonodular synovitis in the knee of a 24-year-old female soccer player: diagnosis, management and summary of tenosynovial giant cell tumours.
    Falster C; Stockmann Poulsen S; Joergensen U
    BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28978573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pexidartinib for the treatment of adult symptomatic patients with tenosynovial giant cell tumors.
    Baldi GG; Gronchi A; Stacchiotti S
    Expert Rev Clin Pharmacol; 2020 Jun; 13(6):571-576. PubMed ID: 32478598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Outcomes of Diffuse or Recurrent Tenosynovial Giant Cell Tumor Treated with Postoperative External Beam Radiation Therapy.
    Baniel C; Yoo CH; Jiang A; von Eyben R; Mohler DG; Ganjoo K; Bui N; Donaldson SS; Million L; van de Rijn M; Oh JM; Hiniker SM
    Pract Radiat Oncol; 2023; 13(3):e301-e307. PubMed ID: 36460182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.